the global pharmaceutical industry n.
Download
Skip this Video
Download Presentation
The Global Pharmaceutical Industry

Loading in 2 Seconds...

play fullscreen
1 / 4

The Global Pharmaceutical Industry - PowerPoint PPT Presentation


  • 136 Views
  • Uploaded on

The Global Pharmaceutical Industry . Sabena Ahmad Iveta Smincakova Dawn Bradbury. PESTEL Analysis. Political: Lighter Regulatory Controls (1960s) Tighter Regulatory Controls on Clinical trials (1970s) Medicare reforms in 2006 extended drug coverage for ageing population Economic:

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'The Global Pharmaceutical Industry' - demi


Download Now An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
the global pharmaceutical industry

The Global Pharmaceutical Industry

Sabena Ahmad

IvetaSmincakova

Dawn Bradbury

pestel analysis
PESTEL Analysis

Political:

  • Lighter Regulatory Controls (1960s)
  • Tighter Regulatory Controls on Clinical trials (1970s)
  • Medicare reforms in 2006 extended drug coverage for ageing population

Economic:

  • Monopsony of the government on drug purchases
  • Parallel trade (free movement of goods across Single European Market)
  • USA contribution to global pharmaceutical sales fell from 60 to 40% in years 2002 to 2005
  • Emerging markets (Latin America, Asian countries e.g. India and China) represented niche markets for pharmaceutical companies
  • Mergers and Acquisitions – Warner-Lambert (USA) & Pfizer (USA)

Social:

  • Increase in consumer expectations
  • Ageing populations (four times higher consumption of health care)
  • Increase in numbers of uninsured people (in USA 46.6m people in 2006)
  • The DTC advertising (the aim is to inform consumers about latest drugs available in the market, to support branding – the expenditure for DTC advertising exceeded $4.5bn in 2006)
pestel analysis1
PESTEL Analysis

Technological:

  • Usage of high technology for R&D
  • Five types of industries – Ethical, Generic, Biotech, OTC and Vaccine
  • Introduction of the ‘blockbusters’ (sales reached $2bn between 1998 and 2003)

Legal:

  • Legislation Setting Fixed Period On Patent Protection (20 years)
  • Government agency ensuring safety & effectiveness of the new drugs (Food and Drug Administration-FDA, National Institute for Clinical Excellence-NICE)
  • Issues of fake drugs (the drug market is estimated over 10% globally)

Environmental:

  • There is no information on this factor in the case study
key drivers of change
Key Drivers of Change
  • Technology
  • Innovation
  • Branding (marketing and advertising)
  • Ethical issues
  • Globalisation of the market
  • Emerging markets
  • Ageing population
  • Regulatory law